• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    1. Process for the preparation of compounds having the N-demethylmorphinane structure of the general formula (III) see diagramm : EP0168686,P8,F1 wherein Z is CH2 -CH2 or CH=CH, Y is an oxygen atom or a group R3 and R4 wherein R3 is a hydrogen atom, a hydroxy group, an acyloxy group having from 1 to 3 carbon atoms or a benzoyloxy group, its spatial configuration being alpha, R4 is a hydrogen atom, a halogen atom, a hydroxy group, an alkyl group having from 1 to 3 carbon atoms, an acyloxy group having from 1 to 3 carbon atoms, a benzoyloxy or azido group, its spatial configuration being beta, R2 is hydrogen atom, an acyloxy group having from 1 to 3 carbon atoms or a benzoyloxy group, R1 is a hydrogen atom, an alkyl group having from 1 to 5 carbon atoms, an aryl or aralkyl group, an acyl group having from 1 to 3 carbon atoms or a benzoyl group, with the proviso that when R3 is a hydrogen atom, a hydroxy group, an acyloxy or benzoyloxy group, R4 is a hydrogen atom or an alkyl group, and when R4 is a hydrogen atom, a halogen atom, a hydroxy group, an acyloxy, benzoyloxy or azido group, R3 is a hydrogen atom, by reaction of morphinane alkaloids of the general formula (I) see diagramm : EP0168686,P9,F2 in which Z, Y, R1 and R2 have the definitions given above, with phosgene or diphosgene at a temperature of from 0 to 1208C in a solvent, and subsequent hydrolysis of the resulting N-chlorocarbonyl-N-demethyl derivative of the general formula (II) see diagramm : EP0168686,P9,F3 in which Z, Y, R1 and R2 have the meanings given above, with a mineral acid, which process is characterized in that the reaction with phosgene or diphosgene is carried out in 1,2-dichloroethane in the presence of alkali metal carbonates or alkali metal hydrogen carbonates, and then, without isolation, the resulting N-chlorocarbonyl-N-demethyl derivative of the general formula (II) is heated with 5 % hydrochloric acid.
    公开号:SU1398776A3
    申请号:SU853923700
    申请日:1985-07-16
    公开日:1988-06-15
    发明作者:Хостафи Шандор；Тимар Тибор；Надь Юлиана；Фабиан Илона
    申请人:Алкалоида Ведьесети Дьяр (Инопредприятие)；
    IPC主号:
    专利说明:


    cm
    The invention relates to an improved process for the preparation of compounds of the general formula I
    kind of, or a hydrogen atom and a hydroxyl group in the position,
    10 for 10 hours is heated with stirring at the boiling point of the reaction mixture. The reaction vessel is rinsed with nitrogen. The inorganic salt is separated by filtration. The solution containing 1,2-dichloroethane is washed three times with 5% hydrochloric acid (cooled with ice), each time using 20 ml of the latter, after which the organic phase is evaporated in
    Rio
    acetic acid).
    H-NMR (CDCl,): 6.66 (dd, H - 1.2; 2H) ;. 4.7 (S, H-5 p; W); 3.9 (s,
    . 35
    by N-deformation of morphinal-20 vacuum. 100 ml of the general formula are added to the residue for 5 hours.
    in a water bath. The mixture is then cooled, and p) and a temperature of 10 C is made basic with a concentrated solution of ammonium hydroxide (pH 9-10). After extraction with chloroform (3 50 ml), the organic phase is washed with sodium chloride solution, and then dried "-.", Above magnesium sulphate. Yield 2.33 g
    where R ,, R ,, Z and Y have the specified you- 30 (). M.p. 50-15Gs (ethyl ether is higher than the value, and used as f
    the N-demethylation agent of phosgene or diphosgene with hydrolysis of the resulting intermediate N-chlorocarbonyl derivative of compound I.
    The purpose of the invention is to simplify the process by using more potent phosgene or diphosgene when I is preparing compounds I.; Melting points are determined by 40 in a Koffler apparatus, data not corrected. MEPSK 5554 silica gel, 60 F foil was used for thin layer chromatography studies. Eluent; benzene: methanol 45 | 3: 2; chloroform: methanol 9: 1 or chloroform: acetone; ethylamine 5: 4: 1 (V / V). The spots exhibit UV light and Dragendorff reagent. The PMR spectra are obtained in an apparatus of the BRUKER JQ W 200 SY type at 200 MHz. The chemical shift is indicated in j (). Mass spectra (MS) are obtained on a VG-7035 apparatus (GC-MS-D3) by electron impact ionization.55
    Example. M-demetiddihydro-de-ion.
    3 g (10 mmol) of dihydrocodeinone are dissolved in 60 ml of 1,2-dichloroethane,
    OSI; zn)
    NA, t / e: 285 23%.
    From the 5% hydrochloric acid solution, by alkalizing with a concentrated solution of ammonium hydroxide and extraction with chloroform, 0.4 g (13%) of dihydrocodeinone is recovered.
    Example 2. N-demethyldihydroporphinone.
    3.3 g (10 mmol) of 3-0-acetyl dihydromorphinone are dissolved in 60 ml of 1,2-dichloroethane, 1 g (10 mmol) of sodium carbonate is added to the solution, then at a temperature of 0 ° C to the mixture is added 19.8 g (12 ml, 100 mmol) of diphosgene are added dropwise with stirring. The mixture is stirred for 30 minutes at 0 ° C, then allowed to warm to room temperature, after which the mixture is heated with stirring for 15 hours at boiling point. The reaction vessel is washed with nitrogen, and the inorganic salt is then filtered. Then the reaction mixture three solution is mixed with 1 g (10 mmol) of sodium carbonate, then with stirring and temperature About With
    the mixture is added dropwise 19.8 g (12, ml, 100 mmol) of diphosphine. The mixture is stirred for 30 minutes at 0 ° C, then it is heated to room temperature, after which
    0 for 10 hours is heated with stirring at the boiling point of the reaction mixture. The reaction vessel is rinsed with nitrogen. The inorganic salt is separated by filtration. The solution containing 1,2-dichloroethane is washed three times with 5% hydrochloric acid (cooled with ice), each time using 20 ml of the latter, after which the organic phase is evaporated in
    0 vacuum. 100 ml is added to the residue. The mixture is heated for 5 hours.
    acetic acid).
    H-NMR (CDCl,): 6.66 (dd, H - 1.2; 2H) ;. 4.7 (S, H-5 p; W); 3.9 (s,
    () M.p. 50-15Gs (ethyl ester f
    OSI; zn)
    NA, t / e: 285 23%.
    From the 5% hydrochloric acid solution, by alkalizing with a concentrated solution of ammonium hydroxide and extraction with chloroform, 0.4 g (13%) of dihydrocodeinone is recovered.
    Example 2. N-demethyldihydroporphinone.
    3.3 g (10 mmol) of 3-0-acetyl dihydromorphinone are dissolved in 60 ml of 1,2-dichloroethane, 1 g (10 mmol) of sodium carbonate is added to the solution, then at a temperature of 0 ° C to the mixture is added 19.8 g (12 ml, 100 mmol) of diphosgene are added dropwise with stirring. The mixture is stirred for 30 minutes at 0 ° C, then allowed to warm to room temperature, after which the mixture is heated with stirring for 15 hours at boiling point. The reaction vessel is washed with nitrogen, and the inorganic salt is then filtered. Then the reaction mixture three ra313987764
    for 5% hydrochloric acid MCj m / e: 265 100%; 215 (50%).
    each time using 20 ml of the latter each time, and the organic phase is evaporated in vacuo. 100 ml of water are added to the residue and the mixture is heated at boiling point for 8 hours. The mixture is then cooled to a temperature of 10 ° C. The product hydrochloride is precipitated as a crystalline substance. It is filtered and washed with cold water. Yield 2.15 g (70%); hydrochloride Foundation, SemiExample A. N-demethyldihydro-codon.
     3.34 g (10 mmol) of 6-0-acetyl-hydrodein is N-demethylated in Example 3. After acid hydrolysis by cooling, the hydrochloric acid salt of the product is not separated from the solution into the precipitate, therefore, after direct alkalinization with concentrated ammonium hydroxide solution is obtained by extracting precipitate, therefore, after direct alkalinization with a concentrated solution of ammonium hydroxide, it is obtained by extracting from it, m.p.
    In Example 1, out of 5% hydrochloric acid solution, the irradiated substance is regenerated.
    Example 3. N-demethylcodeine.
    3.4 g (10 mmol) of the b-O-acetylgenerate is dissolved in 80 ml of 1,2-dichloroethane, 1 g (10 mmol) of sodium carbonate is added to the solution, then, with stirring and at a temperature of 0 ° C, the mixture is added , 8 g (12 ml, 100 mmol) of diphosphogen. The mixture is stirred for 30 minutes at a temperature, then allowed to warm to room temperature, after which the mixture is heated for 20 hours at boiling temperature. The reaction vessel is rinsed with nitrogen, the inorganic salt is filtered. The organic phase is washed three times with 5% hydrochloric acid, using each time 20 ml of the latter, and then evaporated. The residue with 60 ml of 5% hydrochloric acid is heated for 5 hours at the boiling point of the mixture. The mixture is then cooled to a temperature below, a crystalline product is precipitated, which is filtered and rinsed with ice-cooled water. The crystalline hydrochloride is dissolved in water, the solution is alkalinized with a concentrated ammonium hydroxide solution, extraction is carried out with chloroform, the chloroform phase is dried and evaporated. The base obtained in this way is crystallized from acetone or ethyl acetate acetic acid. The yield of 2.3 g (80%). M.p. 185 ° C.
    PMR spectrum (CDCl 3): 6.65 (dd, H-1, 2; 2H); 5.7 (ha, H-8; 1H); 5.3 (t, H-7; 1H); 4.9 (d, H-5 | a; F); 4.2 (t, H-6/3; IH); 3.8 (S, OMe; 3N).
    300-303 seconds, with chloroform, and then crystallized from ethyl alcohol. Output
     .
    1.9 g (66%). M.p. 194 C.
    H-NMR (CDCl,): 6.7 (dd, H-1.2 2H); 4.6 (d, 1H); 4.1 (t, H-6p; 1H); 3.8 (S, OM.e; ЗН).
    20 MS, m / e: 287 100%.
    PRI me R 5. N-demethylmorphine. 3.7 g (10 mmol) of 3,6-di-O-acetylmorphine are dissolved in 100 ml of 1,2-dichloroethane, and then in Example 3
    25 N-demethylation was performed. After cooling the hydrochloric acid solution, the pH is adjusted to 9 by the addition of a concentrated ammonium hydroxide solution. The product was precipitated in crystalline form, filtered and washed with cold water. Yield 2.1 g (77%); the first fraction of 1.8 g; from an alkaline solution in a mixture of chloroform and isopropanol (3: 1, v / v), as a result of the extraction, a second fraction is obtained in an amount of 0.3 g. 274-7 S.
    H-NMR (DMSO-de): 6.4 (dd, H-1,2; 2H); 5.6 (t, H-8; 1H); 5.2 (t,
    40 H-7; 1H); 4.7 (dd, W); 4.1 (t, W). ,
    MS, ha / e: 271 / M; 100%; 201 (51%). PRI me R 6. N-demethyldihydro-morphine.
    45 3.71 g (10 mmol) of 3,6-0-acetyl dihydromorphine are dissolved in 100 ml of 1,2-dichloroethane, after which, in example 5, demethylation is carried out. The output of 1.65 g (60%). M.p. 262-6 ° C.
    50 PMR spectrum (DMSO-dg): 6.5 (dd,
    H-1,2; 2H); 4.2 (d, H-5/3; 1H); 3.8 (t, H-.6p; 1H).
    MS, m / e: 273 100%; 228%; 150 (45%).
    55 PRI me R 7. 3-Ethyl ester of N-demethylmorphine.
    3.55 g (10 mmol) of 6-0-acetyl ethmorphine is N-demethylated
    Example A. N-demethyldihydro-codon.
    3.34 g (10 mmol) of 6-0-acetohydro-hydrodeine is N-demethylated in Example 3. After acid hydrolysis by cooling, the hydrochloric acid salt of the product is not separated from the solution into the precipitate, therefore, after direct alkalinization with a concentrated solution ammonium hydroxide is obtained by extraction with chloroform, and then crystallized from ethyl alcohol. Output
    in Example 3, the hydrochloride of the product is precipitated out as a result of cooling. It is filtered off and washed with cold water. A base is obtained from the obtained substance, which is crystallized from ethyl alcohol. Yield 2.5 g (84%). T „pl. 156-7 s
    Example 8 of about 3 N-demethyldihydromorphine ethyl ester. 3.57 g (10 mmol) of 6 -0-acetyl diggd | roethylmorphine are subjected to N-demethylation as in Example 4. From a hydrochloric-LUTE solution, as a result of alkalisation and extraction, a product is obtained5 which crystallizes from ethyl ether acetic acid, Vg- | course 2.32 g (77%). Tlsho 128-131 ° C.: PMR spectrum (CDC1,); 6., 6 (dd, H-1.2 2H); 4.5 (d, H-5B; 11); 4.1 (m,,; 2H); 3, 95 (m, H-6/3; 1H); 1,4 (t, 0-CH., - CH ,; ZI).
    PRI me R 9. H-demethyl, Esoxy-Codeine-E.
    I 1.42 g (5 mmol) of deoxycodeine-E | was dissolved in 50 ml of 1,2-dichloroethane. 0.5 g (5 mmol) of sodium carbonate was added to the solution, followed by the suspension of hydrobromide to the prepared suspension. Mp.307 (theory. Mp. 311-312 C).
    PRI me R 10. N-dimetyuchgidpro. deoxycodeine-E.
    1.4 g (5 mmol) of dihydrodesoxyoxycodeine-E was used as the starting compound, and in Example 9 it was obtained
    10 0.45 g (33%) of crystalline N-demethyldihydrodeoxysoxodein-E. After crystallization from ethyl acetate, m.p. 91-92 C (theory. Pl. 92-94 ° C).
    15 Example 11 - (optional). K-demethyldihydrocodeine,
    1.5 g (5 mmol) of dihydrocodeinone are dissolved in 50 ml of anhydrous benzene, suspended in the prepared
    20 to a solution of 0.5 g of sodium carbonate and added to the suspension dropwise over 1 hour with stirring and a temperature of 1.0–15 ° C of a solution of 6 ml (50 mmol of diphosgene in 30 ml of benzene. After this, the mixture ceases to cool, stir it and boil for 24 hours. Then it is cooled to room temperature and the inorganic salt is filtered off, and the solution is treated and cooled is added dropwise in Example 30. The yield is 0.85 g (61% of l m 6.0 ml (50 mm: ol) of diphosgene. After theoretical yield) N-demethyldi
    Example 12 (optional). N-demethylation of codeine using 35 phosgene ..
    3.4 g (10 mmol) of 6-0-acetylcodeine are dissolved in 30 ml of anhydrous 40
    After stirring for 30 minutes, cooling is stopped. After that, the mixture is heated for 15 hours under ne; stirring at its boiling point. After cooling, rinse with nitrogen, the inorganic salt is filtered 5 and the organic phase is washed twice with cold hydrochloric acid, each time using 20 ml of this ACID} and sodium chloride solution. Dichloroethane was distilled off in vacuo, 60 ml of water was added to the obtained residue, after which the mixture was heated on a water bath for 8 hours. After cooling, it was basified (PX 10) with concentrated ammonium hydroxide solution and extracted three times with chloroform, using 30 times each time ml of the latter. After drying the chloroform phase with magnesium sulphate, N-demethyldesoxycodeine-E (O, 6 g, 60%) is evaporated in vacuo, which according to chromatography in a thin layer is a homogenous gene substance. The base is not crystalline, but when its alcohol solution is acidified with 49% hydrobromic acid
    40 ml of a 20% phosgene solution in toluene is added dropwise with stirring to the prepared solution. The reaction mixture was allowed to stand at room temperature for 5 days. After flushing the reaction mixture with nitrogen, it is processed 45 in Example 3.
    Yield 1.4 g (49% of theoretical yield) of norkodein.
    50
    权利要求:
    Claims (1)
    [1]
    Invention Formula
    The method of obtaining derivatives of N-de-methyl-morphines of general formula I
    . Rz
    Have
    crystalline hydrobromide. Mp.307 (theory. Mp. 311-312 C).
    PRI me R 10. N-dimetyuchhydgidrodeoksikodein-E.
    1.4 g (5 mmol) of dihydrodesoxyoxycodeine-E was used as the starting compound, and in Example 9 it was obtained
    0.45 g (33%) of crystalline N-demethyldihydrodeoxysoxodein-E. After crystallization from ethyl acetate, m.p. 91-92 C (theory. Pl. 92-94 ° C).
    Example 11 - (additional). K-demethyldihydrocodeine,
    1.5 g (5 mmol) of dihydrocodeinone are dissolved in 50 ml of anhydrous benzene, suspended in the prepared
    a solution of 0.5 g of sodium carbonate and added to the suspension dropwise over 1 hour with stirring and a temperature of 1.0-15 C of a solution of 6 ml (50 mmol of diphosgene in 30 ml of benzene. After that, the mixture is no longer cooled, stirred and boiled t for 24 h. Then it is cooled to room temperature and inorganic is filtered
    40 ml of a 20% phosgene solution in toluene is added dropwise with stirring to the prepared solution. The reaction mixture was allowed to stand at room temperature for 5 days. After flushing the reaction mixture with nitrogen, it is treated as in Example 3.
    Yield 1.4 g (49% of theoretical yield) of norkodein.
    Invention Formula
    The method of obtaining derivatives of N-de-methyl-morphines of general formula I
    . Rz
    R.
    Z
    J
    where R is hydrogen, C, -C, -alkyl; vj is hydrogen;
    the -CHj -CHj- or -CH-CH-oxygen group or two hydrogen atoms, or a hydrogen atom and a hydroxyl group in the it-position,
    by N-demethylation of the corresponding N-methyl derivatives of general formula I with a demethylation agent in an organic solvent medium in the presence of a base, characterized in that, in order to simplify the process and expand the range of target products of the process, phosgene or diphosgene are used as mole The ratio of morphine N-methylproiodohydrate: phosgene or diphosgene is “1:10”; a chlorinated hydrocarbon such as 1,2-dichloroethane or an aromatic is used as an organic solvent. hydrocarbon, such as benzene or toluene, alkali metal carbonate is used as a base at a molar ratio of N-methyl derivative of morphine: alkali metal carbonate 1: 1 and the process is carried out at 20-100 ° C, followed by hydrolysis of the obtained N-chlorocarbonyl derivative of general formula I by heating to boiling with aqueous or 5% aqueous hydrochloric acid.
    类似技术:
    公开号 | 公开日 | 专利标题
    SU651704A3|1979-03-05|Method of obtaining derivatives of dibenzocycloheptene, racemate or optically active salts thereof
    SU508193A3|1976-03-25|Preparation method - | -6,7-benzomorphanes or morphinanes
    ES2202364T3|2004-04-01|PROCEDURE FOR THE PREPARATION OF AZABICICLIC DERIVATIVES.
    US8293906B2|2012-10-23|Processes for the alkylation of norbuprenorphine with reduced impurity formation
    SU719499A3|1980-02-29|Method of preparing 1,2,3,4,6,7-hexahydro-11 b alpha-h-benzo|-quinolysin derivatives or their salts
    MXPA03003459A|2005-04-29|Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof.
    SU1398776A3|1988-06-15|Method of producing derivatives of n-dimethyl-morphines
    SU479290A3|1975-07-30|The method of obtaining 2- | -6,7 benzomorfan
    SU1722228A3|1992-03-23|Method for synthesis of quinoline carboxylic acid derivatives or its methane-sulphonate salt
    US3903164A|1975-09-02|Pharmacodynamically active amino alkyloxim ethers
    US3978085A|1976-08-31|Process for benz[f]-2,5-oxazocines
    US4870179A|1989-09-26|Process for preparing lysergol derivatives
    JPH07121944B2|1995-12-25|Method for producing N-lower 1-methyl-10α-methoxyl millicergor
    EP0248876B1|1995-03-15|Process for the preparation of 1-methylamino-quinoline-carboxylic acid derivatives
    US5175297A|1992-12-29|Methyl-quinoline derivatives as mefloquin intermediates and process for preparation thereof
    US4927842A|1990-05-22|2,3,4,9-tetrahydro-1H-carbazole acetic acid derivatives, composition and use as anti-inflammatories
    SU931108A3|1982-05-23|Process for producing hexahydrobenzopyrano-|pyridines
    KR890001241B1|1989-04-28|Process for preparing 4-acetyl isoquinolinone
    KR0132188B1|1998-04-17|Preparation process of pyridobenzoxazine carboxylic acid derivatives
    US3290316A|1966-12-06|Alpha-3-pyridylmandelic acid and derivatives thereof
    IE911180A1|1991-10-23|Process for preparing pyridine and quinoline derivatives
    US5055590A|1991-10-08|Preparation of 2,3,4,9-tetrahydro-1H-carbazole acetic acid derivatives
    SU487484A3|1975-10-05|The method of obtaining derivatives of 1-phenoxy-3-aminopropan-2-ol
    IL25453A|1970-03-22|Process for the preparation of 2-amino-imidazoles
    RU2108326C1|1998-04-10|Method of synthesis of 2-carboxy-3-[2-|-ethyl]- -n-methyl-1h-indole-5-methane sulfoneamide
    同族专利:
    公开号 | 公开日
    DE3569244D1|1989-05-11|
    DK322385A|1986-01-18|
    ES8603716A1|1986-01-16|
    AT41933T|1989-04-15|
    CS251792B2|1987-08-13|
    NO161915C|1989-10-11|
    NO161915B|1989-07-03|
    FI852779A0|1985-07-15|
    NO852838L|1986-01-20|
    HUT38645A|1986-06-30|
    YU117485A|1988-04-30|
    RO91516A|1987-06-30|
    HU197750B|1989-05-29|
    CS528085A2|1986-12-18|
    FI81583C|1990-11-12|
    ES544385A0|1986-01-16|
    YU45264B|1992-05-28|
    FI81583B|1990-07-31|
    DK322385D0|1985-07-15|
    FI852779L|1986-01-18|
    BG44029A3|1988-09-15|
    EP0168686A1|1986-01-22|
    DD235639A5|1986-05-14|
    RO91516B|1987-07-01|
    IL78503A|1990-01-18|
    JPS6193184A|1986-05-12|
    PL254552A1|1986-07-15|
    IN166255B|1990-03-31|
    EP0168686B1|1989-04-05|
    IL75509D0|1985-10-31|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    CA948198A|1967-08-04|1974-05-28|Gerhard Walther|Production of cyclic amino compounds|
    DE2254298A1|1972-11-06|1974-05-16|Boehringer Sohn Ingelheim|Heteroarylmethyl-normorphines prepn - by alkylation of normorphine etc., antidotes for opiate poisoning|
    DE2727805A1|1977-06-21|1979-01-04|Goedecke Ag|METHOD FOR PRODUCING OXYNORMORPHONE|NZ586203A|2007-12-17|2012-10-26|Mallinckrodt Llc|Process and compounds for the production ofopiates|
    WO2009078988A1|2007-12-17|2009-06-25|Mallinckrodt Inc.|Sinomenine derivatives and processes for their synthesis|
    GB2482826B|2009-05-12|2015-03-11|Univ Texas|Synthesis of morphine and related derivatives|
    AU2010357625B2|2010-07-16|2015-04-23|Mallinckrodt Llc|-morphinans as antagonists of Toll-like receptor 9 and therapeutic uses thereof|
    JP2014526467A|2011-09-08|2014-10-06|マリンクロッドエルエルシー|Preparation of alkaloids without isolation of intermediates|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    HU842774A|HU197750B|1984-07-17|1984-07-17|Process for n-demethylation of morphine alkaloids|
    [返回顶部]